The endoplasmic reticulum chaperone BiP: a target for immunogenic cell death inducers?

Oliver Kepp; Lucillia Bezu; Guido Kroemer

doi:10.1080/2162402X.2022.2092328

The endoplasmic reticulum chaperone BiP: a target for immunogenic cell death inducers?

Oliver Kepp, Lucillia Bezu, Guido Kroemer

Résultats de recherche: Contribution à un journal › Editorial

5 Citations (Scopus)

langue originale	Anglais
Numéro d'article	2092328
journal	OncoImmunology
Volume	11
Numéro de publication	1
Les DOIs	https://doi.org/10.1080/2162402X.2022.2092328
état	Publié - 1 janv. 2022

Accès au document

10.1080/2162402X.2022.2092328

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{384bf6638e654864beebe01411458d28,

title = "The endoplasmic reticulum chaperone BiP: a target for immunogenic cell death inducers?",

author = "Oliver Kepp and Lucillia Bezu and Guido Kroemer",

note = "Funding Information: OK receives funding by the DIM ELICIT initiative of the Ile de France and Institut National du Cancer (INCa); GK is supported by the Ligue contre le Cancer ({\'e}quipes labellis{\'e}es, Program “Equipe labelis{\'e}e LIGUE”; no. EL2016.LNCC (VT/PLP)); Agence National de la Recherche (ANR) – Projets blancs; ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases; AMMICa US23/CNRS UMS3655; Association pour la recherche sur le cancer (ARC); Association “Le Cancer du Sein, Parlons-en!”; Canc{\'e}rop{\^o}le Ile-de-France; Chancellerie des universit{\'e}s de Paris (Legs Poix), Fondation pour la Recherche M{\'e}dicale (FRM); a donation by Elior; European Research Area Network on Cardiovascular Diseases (ERA-CVD, MINOTAUR); Gustave Roussy Odyssea, the European Union Horizon 2020 Project Oncobiome; Fondation Carrefour; INCa; Inserm (HTE); Institut Universitaire de France; LeDucq Foundation; the LabEx Immuno-Oncology (ANR-18-IDEX-0001); the RHU Torino Lumi{\`e}re; the Seerave Foundation; the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); and the SIRIC Cancer Research and Personalized Medicine (CARPEM). ",

year = "2022",

month = jan,

day = "1",

doi = "10.1080/2162402X.2022.2092328",

language = "English",

volume = "11",

journal = "OncoImmunology",

issn = "2162-4011",

number = "1",

}

TY - JOUR

T1 - The endoplasmic reticulum chaperone BiP

T2 - a target for immunogenic cell death inducers?

AU - Kepp, Oliver

AU - Bezu, Lucillia

AU - Kroemer, Guido

N1 - Funding Information: OK receives funding by the DIM ELICIT initiative of the Ile de France and Institut National du Cancer (INCa); GK is supported by the Ligue contre le Cancer (équipes labellisées, Program “Equipe labelisée LIGUE”; no. EL2016.LNCC (VT/PLP)); Agence National de la Recherche (ANR) – Projets blancs; ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases; AMMICa US23/CNRS UMS3655; Association pour la recherche sur le cancer (ARC); Association “Le Cancer du Sein, Parlons-en!”; Cancéropôle Ile-de-France; Chancellerie des universités de Paris (Legs Poix), Fondation pour la Recherche Médicale (FRM); a donation by Elior; European Research Area Network on Cardiovascular Diseases (ERA-CVD, MINOTAUR); Gustave Roussy Odyssea, the European Union Horizon 2020 Project Oncobiome; Fondation Carrefour; INCa; Inserm (HTE); Institut Universitaire de France; LeDucq Foundation; the LabEx Immuno-Oncology (ANR-18-IDEX-0001); the RHU Torino Lumière; the Seerave Foundation; the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); and the SIRIC Cancer Research and Personalized Medicine (CARPEM).

PY - 2022/1/1

Y1 - 2022/1/1

UR - http://www.scopus.com/inward/record.url?scp=85133044104&partnerID=8YFLogxK

U2 - 10.1080/2162402X.2022.2092328

DO - 10.1080/2162402X.2022.2092328

M3 - Editorial

C2 - 35756845

AN - SCOPUS:85133044104

SN - 2162-4011

VL - 11

JO - OncoImmunology

JF - OncoImmunology

IS - 1

M1 - 2092328

ER -